Mycotic aortic aneurysm due to intravesical BCG immunotherapy: Clinical manifestations and diagnostic challenges

Brittany J. Holmes, Richard W. LaRue, James H. Black, Kim Dionne, Nicole M. Parrish, Michael T. Melia

Research output: Contribution to journalArticle


A live, attenuated form of Mycobacterium bovis, bacillus Calmette-Guérin (BCG), is commonly used as intravesical immunotherapy for non-invasive urothelial bladder carcinoma. While complications are rare, dissemination can occur. A case of mycotic aortic aneurysm following BCG administration with recovery of Mycobacterium bovis in culture is reported. A review of the published experience with this problem is also presented.

Original languageEnglish (US)
Pages (from-to)60-65
Number of pages6
JournalInternational Journal of Mycobacteriology
Issue number1
StatePublished - Mar 2014



  • Aorta
  • Bacillus Calmette-Guérin (BCG)
  • Mycobacterium bovis
  • Mycotic aneurysm
  • Psoas muscle abscess

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this